Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical Industries Limited (TEVA)
:TEVA
TEVA Stock Chart & Stats
$19.42
$0.18(0.83%)
At close: 4:00 PM EST
$19.42
$0.18(0.83%)
Day’s Range― - ―
52-Week Range$12.47 - $22.80
Previous CloseN/A
Volume1.13M
Average Volume (3M)10.17M
Market Cap
$22.77B
Enterprise Value$34.83B
Total Cash (Recent Filing)$2.16B
Total Debt (Recent Filing)$17.52B
Price to Earnings (P/E)―
Beta0.68
Next Earnings
Nov 05, 2025EPS Estimate
0.68Last Dividend Ex-Date
Nov 27, 2017Dividend YieldN/A
Share Statistics
EPS (TTM)0.66
Shares Outstanding1,146,838,700
10 Day Avg. Volume8,602,946
30 Day Avg. Volume10,171,311
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.53
Enterprise Value/Revenue2.09
Enterprise Value/Gross Profit4.22
Enterprise Value/Ebitda18.35
Forecast
1Y Price Target
$24.83Price Target Upside27.86% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Credit RatingManagement expressed a high degree of confidence in achieving an IG credit rating by 2H26.
Product GrowthKey US brands Uzedy, Austedo, and Ajovy saw FY25 guidance raise of ~$100m, indicating strong growth potential.
Product StrategyTEVA’s launch of XR formulation and increased investment to support the brand are likely helping to improve uptake.
Bears Say
Pricing ConcernsPending Austedo IRA pricing outcome has been a major stock overhang.
US Generics PerformanceUS generics missed forecast, mainly due to lower g-Revlimid contribution.
Teva Pharmaceutical News
TEVA FAQ
What was Teva Pharmaceutical Industries Limited’s price range in the past 12 months?
Teva Pharmaceutical Industries Limited lowest stock price was $12.46 and its highest was $22.80 in the past 12 months.
What is Teva Pharmaceutical Industries Limited’s market cap?
Teva Pharmaceutical Industries Limited’s market cap is $22.77B.
When is Teva Pharmaceutical Industries Limited’s upcoming earnings report date?
Teva Pharmaceutical Industries Limited’s upcoming earnings report date is Nov 05, 2025 which is in 14 days.
How were Teva Pharmaceutical Industries Limited’s earnings last quarter?
Teva Pharmaceutical Industries Limited released its earnings results on Jul 30, 2025. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.617 by $0.043.
Is Teva Pharmaceutical Industries Limited overvalued?
According to Wall Street analysts Teva Pharmaceutical Industries Limited’s price is currently Undervalued.
Does Teva Pharmaceutical Industries Limited pay dividends?
Teva Pharmaceutical Industries Limited pays a Quarterly dividend of $0.085 which represents an annual dividend yield of N/A. See more information on Teva Pharmaceutical Industries Limited dividends here
What is Teva Pharmaceutical Industries Limited’s EPS estimate?
Teva Pharmaceutical Industries Limited’s EPS estimate is 0.68.
How many shares outstanding does Teva Pharmaceutical Industries Limited have?
Teva Pharmaceutical Industries Limited has 1,146,838,700 shares outstanding.
What happened to Teva Pharmaceutical Industries Limited’s price movement after its last earnings report?
Teva Pharmaceutical Industries Limited reported an EPS of $0.66 in its last earnings report, beating expectations of $0.617. Following the earnings report the stock price went up 1.753%.
Which hedge fund is a major shareholder of Teva Pharmaceutical Industries Limited?
Currently, no hedge funds are holding shares in TEVA
Teva Pharmaceutical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Price Target Potential
57.35% Upside
Analyst Consensus
Strong Buy
Average Price Target:
$24.83 (27.86% Upside)
$24.83 (27.86% Upside)
Blogger Sentiment
Bullish
TEVA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 3.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $21.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 8.8%
Last 30 Days ▲ 8.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.18%
12-Months-Change
Fundamentals
Return on Equity
-2.31%
Trailing 12-Months
Asset Growth
-2.92%
Trailing 12-Months
Company Description
Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty pharmaceuticals, headquartered in Petah Tikva, Israel. The company primarily operates in two segments: Generics, which includes a broad portfolio of generic medicines across various therapeutic areas, and Specialty, which focuses on complex and innovative medications, including branded drugs for neurological and respiratory conditions. Teva's extensive product range includes active pharmaceutical ingredients (APIs) and over-the-counter (OTC) products, positioning it as a vital player in the global healthcare landscape.
TEVA Company Deck
TEVA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive overall sentiment driven by strong growth in the innovative portfolio and strategic advancements in the pipeline, despite challenges in the generics market and uncertainties regarding tariffs.View all TEVA earnings summariesTEVA Revenue Breakdown
54.45% North America
32.42% Europe
13.12% International Markets
TEVA Stock 12 Month Forecast
Average Price Target
$24.83
▲(27.86% Upside)
Technical Analysis
Dr Reddy's Laboratories
―
Viatris
―
Neurocrine
―
Perrigo Company
―
Amneal Pharmaceuticals
―
Ownership Overview
0.43% Insiders
6.78% Mutual Funds
0.74% Other Institutional Investors
88.18% Public Companies and Individual Investors